Chemicals

Savillex completes acquisition of Entegris life sciences fluid management unit

Deal adds single-use bioprocessing bags, assemblies and components to Savillex’s high-purity fluid handling portfolio.

Sienna VossOctober 21, 20265 min read5 views
Translucent single-use bioprocessing bags, tubing assemblies and precision components converge in a clean manufacturing setting, illustrating a combined fluid-handling portfolio.

Savillex, LLC has completed its acquisition of Entegris, Inc.’s Life Sciences Fluid Management business, adding a portfolio of single-use bioprocessing and pharmaceutical manufacturing products to its high-purity fluid handling offerings.

The acquired business includes Aramus and PE bags, single-use assemblies and components used in discovery, clinical and commercial manufacturing. Savillex said the combination broadens its life sciences range and strengthens its ability to support customers from early research through commercial production.

Portfolio and capabilities

Savillex, based in Eden Prairie, Minn., supplies high-purity fluid handling solutions for life science and laboratory applications. Entegris, based in Billerica, Mass., is selling a business whose products are used in bioprocessing workflows. Savillex said the acquired team and technologies will add technical expertise and expand its single-use offering.

CEO Eric Giesing said the Aramus line fits with Savillex’s existing Savillex, Containment and Bioprocessing offerings. He said the deal broadens the company’s portfolio for biopharmaceutical and pharmaceutical customers and that Savillex will continue investing in technologies intended to help customers accelerate development and production of critical therapies.

Chris Bedi, general manager of Fluid Management at Savillex, said the combined portfolio complements Savillex’s capabilities and is expected to support partners across drug development. Savillex said it remains committed to innovation, quality and customer partnerships as it expands for biopharmaceutical and pharmaceutical manufacturers.

EC M&A served as financial advisor and Sidley Austin LLP as legal counsel to Savillex. The companies did not disclose the transaction terms.